DealBio
All collections

Investor Intelligence

13 Patient Monitoring Investors in Europe

European investors with demonstrated activity across remote patient monitoring, wearable biosensors, virtual wards and connected clinical-care platforms.

Published
  • Patient Monitoring
  • Remote Patient Monitoring
  • Wearables
  • Digital Health
  • Europe

Patient monitoring now spans both regulated clinical software and wearable sensing. European financings range from hospital-led remote monitoring platforms to continuous sensors, bringing together digital-health specialists, generalist VCs and strategic investors with healthcare mandates.

DealBio selected 13 investors with evidenced relevance to patient monitoring in Europe, using current investor research, financing precedents and public verification where needed.

Balderton Capital

European venture firm investing from early stage through growth.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables · Metabolic health
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Balderton co-led Sava Technology’s $19 million Series A in 2025 after backing the company earlier. Sava is developing a wearable multi-molecule biosensor for continuous measurement of biomarkers beneath the skin, giving Balderton repeated exposure to next-generation patient monitoring.

Pentland Ventures

Venture investor backing consumer and technology companies.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables
Investment markets
United Kingdom
Investor type
VC

Relevant investment

Pentland Ventures co-led Sava Technology’s $19 million Series A. Sava’s wearable microsensor is designed for continuous biomarker monitoring, with its first product focused on continuous glucose measurement.

Norrsken VC

European impact VC investing in technology companies addressing major societal challenges.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables · Digital health
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Norrsken VC participated in Sava Technology’s $19 million Series A. Sava is building a wearable biosensor platform for real-time molecular monitoring, linking the investment directly to continuous patient data and preventive health.

JamJar Investments

UK consumer venture fund backing technology-enabled brands and platforms.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables
Investment markets
United Kingdom
Investor type
VC

Relevant investment

JamJar participated in Sava Technology’s $19 million Series A. Sava’s platform uses minimally invasive microsensors to monitor molecules beneath the skin continuously and transmit insights to a phone.

Italian Founders Fund

Italian early-stage venture fund backing technology companies.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables
Investment markets
United Kingdom · Italy
Investor type
VC

Relevant investment

Italian Founders Fund participated in Sava Technology’s $19 million Series A. The company’s wearable biosensor platform is designed for continuous biomarker monitoring and personalised health applications.

Athletico Ventures

Early-stage investor focused on sports, health and consumer technology.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables · Consumer health
Investment markets
France · United Kingdom
Investor type
VC

Relevant investment

Athletico Ventures joined Sava Technology’s $19 million Series A. Sava’s multi-molecule wearable biosensor provides a direct patient-monitoring precedent at the intersection of wearables, metabolic health and continuous biomarker measurement.

Bertelsmann Investments

Strategic investment arm of Bertelsmann with dedicated digital-health activity.

Stage
Series A · Growth
Sector / Focus
· Virtual care · Digital health
Investment markets
Germany · United Kingdom · Europe
Investor type
Strategic investor

Relevant investment

Bertelsmann Investments invested €5 million in Doccla in 2023 and later participated in its £35 million Series B. Doccla provides virtual wards and remote patient monitoring using connected devices that track vital signs from patients at home.

Acton Capital

European growth and venture investor backing technology companies.

Stage
Series A · Growth
Sector / Focus
Remote patient monitoring · Digital health
Investment markets
Germany · France · Europe
Investor type
VC

Relevant investment

Acton Capital invested in Sêmeia’s €21 million financing in 2026. Sêmeia operates a multi-pathology remote patient-monitoring platform that structures outpatient data and generates targeted alerts for clinicians.

XAnge

European early-stage venture firm investing in technology companies.

Stage
Seed · Series A
Sector / Focus
Patient monitoring · Virtual care · Digital health
Investment markets
France · Europe
Investor type
VC

Relevant investment

XAnge participated in Sêmeia’s €21 million financing in 2026. Sêmeia has scaled remote monitoring in nephrology and is expanding its platform to additional conditions and clinical-research use cases.

Iberis Capital

Portuguese investment manager backing growth companies and venture-stage technology.

Stage
Series A · Growth
Sector / Focus
Remote patient monitoring · Digital health
Investment markets
Portugal · Europe
Investor type
VC

Relevant investment

Iberis Capital led Hope Care’s €6 million Series A in September 2026. Hope Care develops a regulated remote patient-monitoring platform for hospital-led care beyond the hospital, with programmes operating across multiple European markets.

EMV Capital

UK investment firm focused on deep tech, life sciences and technology-enabled healthcare.

Stage
Seed · Series A
Sector / Focus
Remote patient monitoring · Virtual care
Investment markets
United Kingdom · Europe
Investor type
VC / Venture builder

Relevant investment

EMV Capital led financing for Wanda Health, including a £1.9 million funding package in 2025. Wanda combines remote patient monitoring, virtual care and AI to identify deterioration in patients with acute and chronic disease.

BrightCap Ventures

European early-stage VC investing in technology and healthcare companies.

Stage
Seed
Sector / Focus
Patient monitoring · Cardiovascular diagnostics · Home diagnostics
Investment markets
Czech Republic · Europe
Investor type
VC

Relevant investment

BrightCap Ventures backed Kardi Ai at seed stage. Kardi Ai applies artificial intelligence to cardiovascular data to identify abnormalities and support ongoing cardiac monitoring, giving BrightCap a direct patient-monitoring and home-diagnostics precedent.

Solo Investments

UK investment firm backing growth-stage consumer and technology businesses.

Stage
Series A
Sector / Focus
Patient monitoring · Wearables
Investment markets
United Kingdom
Investor type
Investment firm

Relevant investment

Solo Investments participated in Sava Technology’s $19 million Series A. Sava is developing a wearable platform for continuous molecular monitoring, including a microsensor-based .

Methodology

DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.